A phase i/II clinical trial to investigate fucosylated tregs in prevention of gvhd
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA192601
- Recipient
-
Targazyme, Inc. UEI NJG4X7NZ4BM1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,526,626
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Carlsbad, CA 92011, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $467,137 | |
| Original award | $1,059,489 |
Quick answers
Who received award R44CA192601?
R44CA192601 was awarded to Targazyme, Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2015.
How much is award R44CA192601 worth?
$1,526,626 has been obligated on R44CA192601.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award